SG11201507720PA - Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor - Google Patents
Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitorInfo
- Publication number
- SG11201507720PA SG11201507720PA SG11201507720PA SG11201507720PA SG11201507720PA SG 11201507720P A SG11201507720P A SG 11201507720PA SG 11201507720P A SG11201507720P A SG 11201507720PA SG 11201507720P A SG11201507720P A SG 11201507720PA SG 11201507720P A SG11201507720P A SG 11201507720PA
- Authority
- SG
- Singapore
- Prior art keywords
- selective inhibitor
- pi3kbeta
- pi3kalpha
- tumoral
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305448 | 2013-04-05 | ||
| PCT/EP2014/056696 WO2014161938A1 (en) | 2013-04-05 | 2014-04-03 | Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507720PA true SG11201507720PA (en) | 2015-10-29 |
Family
ID=48142712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507720PA SG11201507720PA (en) | 2013-04-05 | 2014-04-03 | Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160030440A1 (en) |
| EP (1) | EP2981261A1 (en) |
| KR (1) | KR20150123931A (en) |
| CN (1) | CN105163736A (en) |
| AU (1) | AU2014247032A1 (en) |
| BR (1) | BR112015025101A2 (en) |
| CA (1) | CA2908640A1 (en) |
| MX (1) | MX2015014063A (en) |
| RU (1) | RU2015142258A (en) |
| SG (1) | SG11201507720PA (en) |
| WO (1) | WO2014161938A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA104147C2 (en) * | 2008-09-10 | 2014-01-10 | Новартис Аг | Pyrrolidine dicarboxylic acid derivative and use thereof in the treatment of proliferative diseases |
| SI2448927T1 (en) | 2009-07-02 | 2014-06-30 | Sanofi | Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt phosphorylation inhibitors |
| WO2012062694A1 (en) * | 2010-11-08 | 2012-05-18 | Novartis Ag | Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| US9675616B2 (en) * | 2010-11-11 | 2017-06-13 | Bayer Intellectual Property Gmbh | Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines |
| EP2640367A2 (en) * | 2010-11-15 | 2013-09-25 | Exelixis, Inc. | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
| EP2570127A1 (en) * | 2011-09-16 | 2013-03-20 | Sanofi | Compositions and methods for treating cancer using PI3KB beta inhibitor and MAPK pathway inhibitor, including MEK and RAF inhibitors |
-
2014
- 2014-04-03 RU RU2015142258A patent/RU2015142258A/en not_active Application Discontinuation
- 2014-04-03 KR KR1020157027438A patent/KR20150123931A/en not_active Application Discontinuation
- 2014-04-03 MX MX2015014063A patent/MX2015014063A/en unknown
- 2014-04-03 BR BR112015025101A patent/BR112015025101A2/en not_active IP Right Cessation
- 2014-04-03 US US14/781,890 patent/US20160030440A1/en not_active Abandoned
- 2014-04-03 SG SG11201507720PA patent/SG11201507720PA/en unknown
- 2014-04-03 AU AU2014247032A patent/AU2014247032A1/en not_active Abandoned
- 2014-04-03 CN CN201480020038.3A patent/CN105163736A/en active Pending
- 2014-04-03 WO PCT/EP2014/056696 patent/WO2014161938A1/en active Application Filing
- 2014-04-03 EP EP14714736.7A patent/EP2981261A1/en not_active Withdrawn
- 2014-04-03 CA CA2908640A patent/CA2908640A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015025101A2 (en) | 2017-07-18 |
| CN105163736A (en) | 2015-12-16 |
| WO2014161938A1 (en) | 2014-10-09 |
| KR20150123931A (en) | 2015-11-04 |
| US20160030440A1 (en) | 2016-02-04 |
| RU2015142258A (en) | 2017-05-12 |
| CA2908640A1 (en) | 2014-10-09 |
| AU2014247032A1 (en) | 2015-10-29 |
| MX2015014063A (en) | 2015-12-11 |
| EP2981261A1 (en) | 2016-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274355B (en) | Aza-pyridone compounds and uses thereof | |
| HK1220679A1 (en) | Plant-based compositions and uses thereof | |
| HK1223975A1 (en) | Nanobubble-containing composition and use thereof | |
| HRP20180635T1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| GB201317286D0 (en) | Composition and Use | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| GB201321693D0 (en) | Composition and uses thereof | |
| IL244214B (en) | Thienopiperidine derivative and use thereof | |
| IL240248A0 (en) | Met-binding agents and uses thereof | |
| IL276126B (en) | Compositions comprising l-4-chlorokynurenine and uses thereof | |
| IL240553B (en) | Il-1ß inhibitor composition and use thereof | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| GB2516838B (en) | Fungicidal compositions and their use | |
| GB201322892D0 (en) | Surface and composition | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| SG11201507720PA (en) | Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor | |
| GB201322467D0 (en) | Composition and use | |
| GB201323005D0 (en) | Compounds and uses thereof | |
| GB201305503D0 (en) | Inhibitor | |
| GB201308242D0 (en) | Compositions and uses thereof | |
| GB201320161D0 (en) | Compounds and their uses | |
| GB201301022D0 (en) | Composition and uses thereof |